Charles River Laboratories to Report Q1 2026 Earnings on May 7
Charles River Laboratories (CRL) is set to release its first-quarter 2026 earnings on May 7. Analysts expect a decline in earnings per share (EPS) compared to the previous year, though the company has historically exceeded expectations. CRL has outperformed both the S&P 500 and the Health Care Select Sector SPDR ETF over the past year.
Tickers: $CRL
Topics: Analyst Expectations Earnings Release Financial Performance Stock Performance